John E. Kao - 12 Mar 2026 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Issuer symbol
ALHC
Transactions as of
12 Mar 2026
Net transactions value
-$853,126
Form type
4
Filing time
13 Mar 2026, 18:31:58 UTC
Previous filing
10 Mar 2026
Next filing
17 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KAO JOHN E Chief Executive Officer, Director 1100 W. TOWN & COUNTRY RD., SUITE 1600, ORANGE /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao 13 Mar 2026 0001222028

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale $802,812 -45,938 -2.9% $17.48 1,522,441 12 Mar 2026 Direct F1, F2
transaction ALHC Common Stock Sale $50,313 -2,961 -0.19% $16.99 1,519,480 12 Mar 2026 Direct F1, F3
holding ALHC Common Stock 2,472,641 12 Mar 2026 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
F2 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.035 to $18.03. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.92 to $17.03. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F4 Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.